Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Zoetis Inc (NYSE:ZTS)

40.43
Delayed Data
As of Feb 12
 +1.07 / +2.72%
Today’s Change
37.73
Today|||52-Week Range
55.38
-15.63%
Year-to-Date

Today’s Trading

Previous close39.36
Today’s open39.81
Day’s range39.21 - 40.48
Volume6,734,704
Average volume (3 months)3,862,708
Market cap$19.6B
Dividend yield0.94%
Data as of 4:02pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+14.85%
Earnings growth (this year)+10.05%
Earnings growth (next 5 years)+10.60%
Revenue growth (last year)+4.91%
P/E ratio45.9
Price/Sales4.51
Price/Book15.05

Competitors

 Today’s
change
Today’s
% change
VRTXVertex Pharmaceutica...+3.52+4.42%
PRGOPerrigo Company PLC+3.53+2.61%
MYLMylan NV+0.41+0.98%
INCYIncyte Corp+2.85+4.35%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateFebruary 16, 2016
EPS forecast (this quarter)$0.38
Annual revenue (last year)$4.8B
Annual profit (last year)$583.0M
Net profit margin12.18%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Juan Ramón Alaix
Chief Financial Officer &
Executive Vice President
Paul S. Herendeen
Corporate headquarters
Florham Park, New Jersey

Forecasts

Partner Offers